Central African Republic vs Eastern Mediterranean (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)

Central African Republic
5.3%
in 2024
Eastern Mediterranean (WHO region)
0.5%
in 2024
Central African Republic rank
1st
Eastern Mediterranean (WHO region) rank
4th

Hepatitis B surface antigen (HBsAg) prevalence (%) over time

  • Central African Republic
  • Eastern Mediterranean (WHO region)
0246810201520192024

How they compare

Central African Republic currently reports 5.3% against 0.5% in Eastern Mediterranean (WHO region), a difference of 4.8%.

That makes Central African Republic's figure about 10.6 times Eastern Mediterranean (WHO region)'s.

Across all 10 years both countries report, Central African Republic has been ahead every year.

Central African Republic ranks 1st and Eastern Mediterranean (WHO region) ranks 4th of 194 countries.

Central African Republic has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Central African Republic Eastern Mediterranean (WHO region) Difference Ahead
2010s 10.0% 0.6% 9.5% Central African Republic
2020s 7.0% 0.5% 6.5% Central African Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hepatitis b surface antigen (hbsag) prevalence, Central African Republic or Eastern Mediterranean (WHO region)?
Central African Republic, at 5.3% against 0.5% in Eastern Mediterranean (WHO region) as of 2024.
What is the difference in hepatitis b surface antigen (hbsag) prevalence between Central African Republic and Eastern Mediterranean (WHO region)?
4.8%, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and Eastern Mediterranean (WHO region)?
10 years are reported by both, from 2015 to 2024.
How do Central African Republic and Eastern Mediterranean (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
Central African Republic ranks 1st and Eastern Mediterranean (WHO region) ranks 4th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Eastern Mediterranean (WHO region): Hepatitis B surface antigen (HBsAg) prevalence. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/compare/hepatitis-b-surface-antigen-hbsag-prevalence-percent/central-african-republic/eastern-mediterranean-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hepatitis-b-surface-antigen-hbsag-prevalence-percent/central-african-republic/eastern-mediterranean-who-region/">Central African Republic vs Eastern Mediterranean (WHO region): Hepatitis B surface antigen (HBsAg) prevalence</a> — Statizoid

About this data

Indicator
Hepatitis B surface antigen (HBsAg) prevalence (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
209 places, 2,090 data points, 2015–2024
Last refreshed